Zolbetuximab plus chemotherapy versus immune checkpoint inhibitor regimens by programmed death-ligand 1 combined positive score in locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: a Bayesian network meta-analysis.
- DOI
- 10.1016/j.esmoop.2026.108530
- Published
- 2026-09-16
- Container
- ESMO Open
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2026.108530,
title = {Zolbetuximab plus chemotherapy versus immune checkpoint inhibitor regimens by programmed death-ligand 1 combined positive score in locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: a Bayesian network meta-analysis.},
author = {Shitara K and Rha SY and Klempner SJ and Lordick F and Ranganath R and Oh M and Getzenberg RH and Gourgioti G and Chai X and Yang H.},
year = {2026},
journal = {ESMO Open},
doi = {10.1016/j.esmoop.2026.108530},
url = {https://doi.org/10.1016/j.esmoop.2026.108530}
}RIS
TY - JOUR TI - Zolbetuximab plus chemotherapy versus immune checkpoint inhibitor regimens by programmed death-ligand 1 combined positive score in locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: a Bayesian network meta-analysis. AU - Shitara K AU - Rha SY AU - Klempner SJ AU - Lordick F AU - Ranganath R AU - Oh M AU - Getzenberg RH AU - Gourgioti G AU - Chai X AU - Yang H. PY - 2026 JO - ESMO Open DO - 10.1016/j.esmoop.2026.108530 UR - https://doi.org/10.1016/j.esmoop.2026.108530 ER -
APA
K, S., SY, R., SJ, K., F, L., R, R., M, O., RH, G., G, G., X, C., & H., Y. (2026). Zolbetuximab plus chemotherapy versus immune checkpoint inhibitor regimens by programmed death-ligand 1 combined positive score in locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: a Bayesian network meta-analysis.. ESMO Open. https://doi.org/10.1016/j.esmoop.2026.108530
Source records
- europe-pmc · retrieved 2026-09-25T06:46:13.845Z